EP3853317A4 - Artificial tear, contact lens and drug vehicle compositions and methods of use thereof - Google Patents
Artificial tear, contact lens and drug vehicle compositions and methods of use thereof Download PDFInfo
- Publication number
- EP3853317A4 EP3853317A4 EP19863887.6A EP19863887A EP3853317A4 EP 3853317 A4 EP3853317 A4 EP 3853317A4 EP 19863887 A EP19863887 A EP 19863887A EP 3853317 A4 EP3853317 A4 EP 3853317A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- contact lens
- artificial tear
- drug vehicle
- vehicle compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/137,738 US20190021990A1 (en) | 2016-10-12 | 2018-09-21 | Artificial tear compositions and methods of use thereof |
US16/372,625 US11583496B2 (en) | 2016-10-12 | 2019-04-02 | Drug vehicle compositions and methods of use thereof |
US16/372,582 US20190224136A1 (en) | 2016-10-12 | 2019-04-02 | Artificial tear compositions and methods of use thereof |
US16/372,596 US20190225917A1 (en) | 2016-10-12 | 2019-04-02 | Contact lens compositions and methods of use thereof |
US16/412,943 US20190262290A1 (en) | 2016-10-12 | 2019-05-15 | Drug vehicle compositions and methods of use thereof |
PCT/US2019/051825 WO2020061249A2 (en) | 2018-09-21 | 2019-09-19 | Artificial tear, contact lens and drug vehicle compositions and methods of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3853317A2 EP3853317A2 (en) | 2021-07-28 |
EP3853317A4 true EP3853317A4 (en) | 2022-06-22 |
Family
ID=69887791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19863887.6A Pending EP3853317A4 (en) | 2018-09-21 | 2019-09-19 | Artificial tear, contact lens and drug vehicle compositions and methods of use thereof |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3853317A4 (en) |
JP (1) | JP2022511335A (en) |
CN (1) | CN113227304A (en) |
BR (1) | BR112021005097A2 (en) |
CA (1) | CA3112278A1 (en) |
WO (1) | WO2020061249A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220350163A1 (en) * | 2021-04-29 | 2022-11-03 | Coopervision International Limited | Ws12-releasing contact lens |
CN115671256B (en) * | 2021-07-30 | 2024-04-09 | 四川大学华西医院 | Use of cyclosporin A in combination with diquafosol sodium for the preparation of a medicament for the treatment of dry eye |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140377210A1 (en) * | 2013-06-21 | 2014-12-25 | Gnt, Llc | Artificial tear compositions |
US20180098937A1 (en) * | 2016-10-12 | 2018-04-12 | Ps Therapies Ltd | Artificial tear, contact lens and drug vehicle compositions and methods of use thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2422031C (en) * | 2000-09-13 | 2011-11-15 | Santen Pharmaceutical Co., Ltd. | Ophthalmic solutions comprising difluoroprostaglandin f2 alpha |
WO2009035034A1 (en) * | 2007-09-14 | 2009-03-19 | Rohto Pharmaceutical Co., Ltd. | Ophthalmic composition |
PE20121498A1 (en) * | 2009-12-15 | 2012-11-30 | Foresight Biotherapeutics Inc | NON-IRRITATING OPHTHALMIC COMPOSITIONS OF POVIDONE-IODINE |
US8597629B1 (en) * | 2013-06-21 | 2013-12-03 | Premium Ocular Solutions LLC. | Artificial tear compositions comprising a combination of nonionic surfactants |
JP2018507252A (en) * | 2015-01-26 | 2018-03-15 | ボシュ・アンド・ロム・インコーポレイテッドBausch & Lomb Incorporated | Ophthalmic suspension composition |
US20180161438A1 (en) * | 2015-05-28 | 2018-06-14 | Rohto Pharmaceutical Co., Ltd. | Aqueous Ophthalmic Composition |
-
2019
- 2019-09-19 EP EP19863887.6A patent/EP3853317A4/en active Pending
- 2019-09-19 JP JP2021515543A patent/JP2022511335A/en active Pending
- 2019-09-19 WO PCT/US2019/051825 patent/WO2020061249A2/en unknown
- 2019-09-19 BR BR112021005097-3A patent/BR112021005097A2/en unknown
- 2019-09-19 CA CA3112278A patent/CA3112278A1/en active Pending
- 2019-09-19 CN CN201980077116.6A patent/CN113227304A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140377210A1 (en) * | 2013-06-21 | 2014-12-25 | Gnt, Llc | Artificial tear compositions |
US20180098937A1 (en) * | 2016-10-12 | 2018-04-12 | Ps Therapies Ltd | Artificial tear, contact lens and drug vehicle compositions and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
EP3853317A2 (en) | 2021-07-28 |
WO2020061249A2 (en) | 2020-03-26 |
BR112021005097A2 (en) | 2021-06-08 |
CA3112278A1 (en) | 2020-03-26 |
WO2020061249A3 (en) | 2020-07-23 |
JP2022511335A (en) | 2022-01-31 |
CN113227304A (en) | 2021-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3525885A4 (en) | Artificial tear, contact lens and drug vehicle compositions and methods of use thereof | |
EP3706741A4 (en) | Pharmaceutical composition and use thereof | |
EP3624773A4 (en) | Ophthalmic compositions and methods of use | |
AU2018290633A1 (en) | Conjugate of VEGF-Grab protein and drug, and use thereof | |
EP3500255A4 (en) | Ophthalmic pharmaceutical compositions and uses relating thereto | |
EP3452075A4 (en) | Ophthalmic pharmaceutical composition | |
EP3784268A4 (en) | Combinations of osteopontin and 2'-fucosyllactose for use as medicaments | |
EP3672587A4 (en) | Pharmaceutical compositions for the treatment of ophthalmic conditions | |
EP3685828A4 (en) | Ophthalmic pharmaceutical composition, ophthalmic kit, and pharmaceutical application thereof | |
EP3821012A4 (en) | Retrotransposon-based delivery vehicle and methods of use thereof | |
EP3651747A4 (en) | Compositions and methods for the treatment of eye disorders | |
EP3765095A4 (en) | Ophthalmic compositions, and ocular uses thereof, of indigo carmine | |
EP3721890A4 (en) | Ophthalmic drug preparation and uses thereof | |
EP3744316A4 (en) | Ophthalmic pharmaceutical composition, preparation method therefor and application thereof | |
EP3618882A4 (en) | Biocompatible hydrogel compositions and uses thereof | |
EP3952881A4 (en) | Compositions and methods for the treatment of contact lens discomfort | |
EP3503873A4 (en) | Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof | |
EP3654964A4 (en) | Composition and methods for the treatment of myopia | |
EP3700478A4 (en) | Corneal implant systems and methods | |
EP3672598A4 (en) | Ocular pharmaceutical compositions | |
EP3851121A4 (en) | Human anti-il-33 monoclonal-antibody-containing pharmaceutical composition | |
EP3773654A4 (en) | Polypharmaceutical drug compositions and related methods | |
EP3853317A4 (en) | Artificial tear, contact lens and drug vehicle compositions and methods of use thereof | |
EP3589704A4 (en) | Coating composition comprised of a hydrophilic crosslinker, a hydrophobic crosslinker and optionally a hydrogel and methods of making and using the same | |
EP3946002A4 (en) | Corneal topography system and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210329 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20220524 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61L 12/12 20060101ALN20220518BHEP Ipc: A61K 9/08 20060101ALI20220518BHEP Ipc: C09K 3/00 20060101AFI20220518BHEP |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: PS THERAPY, INC. |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230426 |